Small Cell Lung Cancer Limited Stage clinical trials

Explore recruiting small cell lung cancer limited stage clinical trials.

Recruiting small cell lung cancer limited stage studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Small Cell Lung Cancer Limited Stage trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II randomized Study to evaluate the efficacy and safety of Cisplatin or Carboplatin / Etoposide and concomitant Radiotherapy combined with Durvalumab followed by Maintenance Therapy with Durvalumab versus Cisplatin or Carboplatin / Etoposide and concomitant Radiotherapy in Patients with limited disease Small Cell Lung Cancer.

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase II randomized clinical trial of Tarlatamab as maintenance treatment after sequential chemo-radiotherapy vs sequential chemo-radiotherapy as standard treatment for limited stage SCLC patients not eligible for concurrent chemo-radiotherapy. MERLIN GECP 24/01

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS SCLC) who Have not Progressed Following Concurrent Chemoradiation Therapy (DeLLphi-306)

Austria, Portugal, Poland, France, Sweden, Bulgaria +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

DURVALUNG_A phase II study of durvalumab (MEDI 4736) maintenance in frail limited disease small cell lung cancer patients after thoracic chemoradiotherapy (CRT)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled, Multi-Regional Phase III Clinical Study of Toripalimab Alone or in Combination With Tifcemalimab (JS004/TAB004) as Consolidation Therapy in Patients With Limited-Stage Small Cell Lung Cancer Without Disease Progression Following Chemoradiotherapy

Italy, Romania, Germany, Belgium, Poland, France +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Pembrolizumab (MK-3475) in Combination with Concurrent Chemoradiation Therapy Followed by Pembrolizumab with or without Olaparib (MK-7339), Compared to Concurrent Chemoradiation Therapy Alone in Participants with Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC)

Portugal, Hungary, France, Romania, Belgium, Spain +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Small Cell Lung Cancer Limited Stage trials by city

Small Cell Lung Cancer Limited Stage in Toronto Small Cell Lung Cancer Limited Stage in Vancouver Small Cell Lung Cancer Limited Stage in Montreal Small Cell Lung Cancer Limited Stage in Calgary Small Cell Lung Cancer Limited Stage in Edmonton Small Cell Lung Cancer Limited Stage in Ottawa Small Cell Lung Cancer Limited Stage in Winnipeg Small Cell Lung Cancer Limited Stage in Quebec City Small Cell Lung Cancer Limited Stage in Hamilton Small Cell Lung Cancer Limited Stage in Kitchener Small Cell Lung Cancer Limited Stage in London Small Cell Lung Cancer Limited Stage in Halifax Small Cell Lung Cancer Limited Stage in New York Small Cell Lung Cancer Limited Stage in Los Angeles Small Cell Lung Cancer Limited Stage in Chicago Small Cell Lung Cancer Limited Stage in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease